Cidara Therapeutics, Inc. (CDTX)
NASDAQ: CDTX · Real-Time Price · USD
19.43
+0.80 (4.29%)
At close: May 12, 2025, 4:00 PM
19.43
0.00 (0.00%)
After-hours: May 12, 2025, 4:05 PM EDT
Cidara Therapeutics Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$38.50
Upside
+98.15%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $33 → $35 | Strong Buy | Maintains | $33 → $35 | +80.13% | May 9, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $46 → $47 | Buy | Maintains | $46 → $47 | +141.89% | May 9, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $46 | Buy | Reiterates | $46 | +136.75% | Apr 29, 2025 |
| Needham | Needham | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +80.13% | Apr 10, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Initiates $46 | Buy | Initiates | $46 | +136.75% | Mar 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $24 → $35 | Strong Buy | Maintains | $24 → $35 | +80.13% | Mar 10, 2025 |
| Needham | Needham | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +80.13% | Mar 7, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jan 27, 2025 |
| RBC Capital | RBC Capital | Buy Initiates $34 | Buy | Initiates | $34 | +74.99% | Dec 13, 2024 |
| WBB Securities | WBB Securities | Strong Buy Maintains $40 → $45 | Strong Buy | Maintains | $40 → $45 | +131.60% | Dec 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $24 | Strong Buy | Reiterates | $24 | +23.52% | Nov 11, 2024 |
| Guggenheim | Guggenheim | Strong Buy Initiates $33 | Strong Buy | Initiates | $33 | +69.84% | Nov 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $24 | Strong Buy | Reiterates | $24 | +23.52% | Oct 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $24 | Strong Buy | Reiterates | $24 | +23.52% | Sep 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $24 | Hold → Strong Buy | Upgrades | $24 | +23.52% | Aug 14, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 14, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.